title: In-vivo purging of the circulating clonal T-cells with Alemtuzumab prior to autologous peripheral blood hematopoietic cell mobilization and transplantation.
authors.forename: Andrei
authors.initials: A
authors.lastname: Shustov
authors.forename: Sindhu
authors.initials: S
authors.lastname: Cherian
authors.forename: Allison
authors.initials: A
authors.lastname: Shaw
authors.forename: Toni-Ann
authors.initials: TA
authors.lastname: Lupinacci
authors.forename: David
authors.initials: D
authors.lastname: Maloney
authors.forename: Leona
authors.initials: L
authors.lastname: Holmberg
authors.forename: Ajay K
authors.initials: AK
authors.lastname: Gopal
mesh_terms: D000368:Aged; D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016465:Bone Marrow Purging / Q000379:methods*; D004341:Drug Evaluation / Q000379:methods; D005240:Feasibility Studies; D005260:Female; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods; D006801:Humans; D016411:Lymphoma, T-Cell, Peripheral / Q000628:therapy*; D036102:Peripheral Blood Stem Cell Transplantation / Q000379:methods*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D000074323:Alemtuzumab